$56.83
0.080.14%
At close: -
$56.83
0.000.00%
After Hours: Dec 20, 4:04 PM EDT
Janux Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Janux Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.51 | $-0.33 | -54.5 % |
Jun 2024 | 2024-08-07 | $-0.11 | $-0.31 | 64.5 % |
Mar 2024 | 2024-05-07 | $-0.30 | $-0.33 | 9.09 % |
Dec 2023 | 2024-03-08 | $-0.25 | $-0.40 | 37.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $439.00K | $1.64M | -73.3 % |
Jun 2024 | 2024-08-07 | $8.90M | $767.44K | 1059.3 % |
Mar 2024 | 2024-05-07 | $1.25M | $760.00K | 64.7 % |
Dec 2023 | 2024-03-08 | $2.46M | $750.00K | 228.1 % |
Janux Therapeutics (JANX) is scheduled to report earnings on March 7, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-0.51, which missed the estimate of $-0.33.
The Actual Revenue was $439K, which missed the estimate of $1.6M.
Browse earnings estimates, EPS, and revenue on all stocks.